Agilon Health (AGL) Receivables (2020 - 2026)

Agilon Health (AGL) has reported Receivables for 7 consecutive years, with $899.7 million the latest figure, recorded in Q1 2026.

• Receivables for Q1 2026 came in at $899.7 million, down 27.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $899.7 million (down 27.42% YoY), and the FY2025 annual result was $673.8 million, down 33.75% from the prior year.
• Receivables was $899.7 million for Q1 2026 at Agilon Health, up from $673.8 million in the prior quarter.
• Over five years, Receivables peaked at $1.6 billion in Q1 2024 and troughed at $499.3 million in Q4 2022.
• Average Receivables over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2023.
• Year-over-year, Receivables soared 133.21% in 2023 and sank 33.75% in 2025.
• Over 5 years, Receivables stood at $499.3 million in 2022, then surged by 89.69% to $947.1 million in 2023, then advanced by 7.39% to $1.0 billion in 2024, then tumbled by 33.75% to $673.8 million in 2025, then jumped by 33.53% to $899.7 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $899.7 million in Q1 2026, $673.8 million in Q4 2025, and $947.2 million in Q3 2025.